Fig. 5

The calibration curves used for predicting patient OS at 1-, 3- and 5-years for the training cohort and 1-, 3- and 5-years for the testing cohort. Decision curve analysis evaluated the ability of the nomogram to predict 5-year overall survival in cervical cancer patients in the training (C) and testing (D) cohorts. The nomogram distinguished the risk of cervical cancer patients in the training cohort (E) and the testing cohort (F)